through wyeth australia, wyeth manufactures and sells its extended release formulation of venlafaxine hydrochloride under the name efexor-xr .
the respondents are (respectively) an innovator pharmaceutical company incorporated in the united state of america, wyeth, and its wholly owned australian subsidiary, wyeth australia pty limited ( wyeth and wyeth australia ).
wyeth is encouraging switching from efexor-xr to pristiq.